News Snapshot:
Fosun Pharma to import 100 million doses of BioNTech’s COVID-19 vaccine to China 8:10 PM (Reuters) - Shanghai Fosun Pharmaceutical Group said on Wednesday that BioNTech SE will supply at least 100 million doses of its COVID-19 vaccine, if approved, to mainland China next year. China has not announced supply deals with Western drugmakers, which instead have partnered with private companies in the country. Fosun Pharma will make an initial payment of 125 million euros ($151.84 million) by the end of the year for 50 million doses. Pfizer and BioNTech's COVID-19 vaccine has already received approval for emergency use in...
